← Back to Clinical Trials
Recruiting NCT07075952

NCT07075952 Training App for Inhibitory Control Towards Food

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07075952
Status Recruiting
Phase
Sponsor University of Padova
Condition Obesity &Amp; Overweight
Study Type INTERVENTIONAL
Enrollment 113 participants
Start Date 2025-10-01
Primary Completion 2026-03

Eligibility & Interventions

Sex All sexes
Min Age 16 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Food-specific inhibitory control training delivered through the FoodTraining AppWaiting list

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 113 participants in total. It began in 2025-10-01 with a primary completion date of 2026-03.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The aim of this project is to test the feasibility, acceptability and clinical impact of a mobile app-based intervention (FoodTraining) to strengthen food-related inhibitory control over 4 weeks, in a sample of people with eating or weight disorders (i.e. obesity, binge-eating disorder (BED), or bulimia nervosa (BN)) receiving standard outpatient treatment (i.e., treatment as usual (TAU) encompassing guided self-help or psychotherapy, pharmacological therapy or diet). The training will be offered in addition to TAU (experimental group) and compared to TAU alone (control group). Participants will complete questionnaires to measure eating behaviour, eating disorder psychopathology, symptoms of anxiety, depression and stress, social functioning and quality of life at baseline, 4 and 8 weeks. They will also complete momentary assessments using a mobile application (FoodTracker) to report on food intake along with related thoughts, emotions, and behaviours and will wear small, non-invasive sensors to track real-time fluctuations in glucose levels for 15 days. Participants will also perform a food-related go-no go task and a food-related temporal discounting task at baseline, 4 and 8 weeks. Finally, this study will pilot the use of a semi-structured interview to characterise the history of weight, the appetite system, eating-related habits in the family and learning of eating behaviours and attitudes in people with eating or weight disorders.

Eligibility Criteria

Inclusion Criteria: * BMI in the obesity range (\>30) or a clinician-formulated diagnosis of binge eating disorder or bulimia nervosa; * knowledge of Italian or English; * access to a mobile device (e.g. smartphone, tablet). Exclusion Criteria: * visual impairment not corrected by glasses * a diagnosis of psychosis; * intellectual disability.

Contact & Investigator

Central Contact

Valentina Cardi, PhD

✉ valentina.cardi@unipd.it

📞 +39049827

Principal Investigator

Valentina Cardi, PhD

PRINCIPAL INVESTIGATOR

Department of General Psychology, University of Padova, Padova, Italy

Frequently Asked Questions

Who can join the NCT07075952 clinical trial?

This trial is open to participants of all sexes, aged 16 Years or older, studying Obesity &Amp; Overweight. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07075952 currently recruiting?

Yes, NCT07075952 is actively recruiting participants. Contact the research team at valentina.cardi@unipd.it for enrollment information.

Where is the NCT07075952 trial being conducted?

This trial is being conducted at Padova, Italy.

Who is sponsoring the NCT07075952 clinical trial?

NCT07075952 is sponsored by University of Padova. The principal investigator is Valentina Cardi, PhD at Department of General Psychology, University of Padova, Padova, Italy. The trial plans to enroll 113 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology